Nasdaq
$18.18▲ 0.06%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $3.92BShares out 2.200M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
25- 10.8After-hours26.10.09 06:294Ownership#●●●
Relay Therapeutics, Inc.
Relay Therapeutics insider Sanjiv Patel filed a Form 4 on October 7, 2026, regarding changes in beneficial ownership of securities. This filing serves as an official record of the executive's equity transactions.…more
$18.18+0.06%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.8After-hours26.10.09 06:294Ownership
Relay Therapeutics, Inc.
Relay Therapeutics insider Thomas Catinazzo filed a Form 4 on October 8, 2026, reporting changes in beneficial ownership of securities as of October 6, 2026. This filing serves as an official record of the insider's equity transaction.…more
$18.18+0.06%vs prev closeView filingShare - 10.7After-hours26.10.08 05:35144Ownership
Relay Therapeutics, Inc.
Sanjiv Patel, an insider at Relay Therapeutics, Inc., has filed an SEC Form 144 to report a proposed sale of company shares. This filing serves as a formal notification of the insider's plan to dispose of their holdings.…more
$18.18+0.06%vs prev closeView filingShare
24 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 9.1After-hours26.09.02 05:46#●●●#●●●
Relay Therapeutics to Participate in Two Investor Conferences in September…more
Relay Therapeutics announced that its management will participate in fireside chats at upcoming Wells Fargo and Morgan Stanley healthcare conferences in September. This is a routine investor relations event and does not have a direct impact on the stock price.…more
$18.18+0.06%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 8.6After-hours26.08.07 05:05
●●●●●●●● ●●●●● ●●●●●●
릴레이 테라퓨틱스는 주력 파이프라인인 조베갈리십의 유방암 및 혈관 기형 임상에서 긍정적인 데이터를 확보하며 개발을 가속화하고 있습니다. 약 9억 1천만 달러의 현금 보유고를 바탕으로 2029년까지 안정적인 임상 운영이 가능할 것으로 전망됩니다.…more
$18.18+0.06%vs prev close - 7.30After-hours26.07.31 05:05
●●●●●●●● ●●●●● ●●●●●●
릴레이 테라퓨틱스가 오는 8월 6일 장 마감 후 2026년 2분기 실적 및 주요 기업 성과를 발표합니다. 투자자들은 회사의 핵심 파이프라인인 조베갈리십의 임상 진행 상황과 재무 상태를 확인할 수 있을 전망입니다.…more
$18.18+0.06%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report